Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / DAILY S&P BIOTEC
-
Total 13F shares
-
695,441
-
Share change
-
+309,384
-
Total reported value
-
$14,645,989
-
Put/Call ratio
-
35%
-
Price per share
-
$21.06
-
Number of holders
-
17
-
Value change
-
+$5,214,959
-
Number of buys
-
15
-
Number of sells
-
9
Institutional Holders of DIREXION SHS ETF TR - DAILY S&P BIOTEC (LABD) as of Q4 2025
As of 31 Dec 2025,
DIREXION SHS ETF TR - DAILY S&P BIOTEC (LABD) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
695,441 shares.
The largest 10 holders included
Jump Financial, LLC, CITADEL ADVISORS LLC, BNP PARIBAS FINANCIAL MARKETS, Qube Research & Technologies Ltd, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GTS SECURITIES LLC, Ikarian Capital, LLC, TWO SIGMA SECURITIES, LLC, Tower Research Capital LLC (TRC), and JANE STREET GROUP, LLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.